TECTONIC THERAPEUTIC, INC. Total Liabilities
TECTONIC THERAPEUTIC, INC. (TECX) had Total Liabilities of $13.19 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-06
- 2026-06-30: Liabilities $13.19M.
- 2026-03-31: Liabilities $16.16M.
- 2025-12-31: Liabilities $9.71M.
- 2025-09-30: Liabilities $9.47M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $13.19M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $16.16M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $9.71M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $9.47M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $11.55M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $13.79M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $12.13M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $18.36M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $27.54M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $3.51M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $43.41M 10-K · filed 2025-03-20 | $6.35M 10-K · filed 2024-03-14 |
| 2023-09-30 | $7.66M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $11.80M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $30.01M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $28.58M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $31.41M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $27.90M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $32.18M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $34.36M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $22.88M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $17.10M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $12.98M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $16.89M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $25.38M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $15.78M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $13.20M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $14.50M 10-K · filed 2021-03-18 | |
| 2019-09-30 | $10.45M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $9.36M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $10.58M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $11.29M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $6.16M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $10.41M 10-Q · filed 2018-08-09 | |
| 2017-12-31 | $3.66M 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |